Capital Square, LLC Abb Vie Inc. Transaction History

Capital Square, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 09, 2023	BUY	$138.31 - $165.87 $179,111 - $214,801	1,295 New	1,295 $209,000
Q2 2022 Aug 04, 2022	SELL	$137.62 - $174.96 $1,513 - $1,924	-11 Reduced 0.78%	1,391 $213,000
Q1 2022 May 09, 2022	BUY	$131.98 - $163.75 $185,035 - $229,577	1,402 New	1,402 $227,000
Q3 2021 Nov 02, 2021	SELL	$106.4 - $120.78 $393,148 - $446,282	-3,695 Closed	0 $0
Q2 2021 Aug 04, 2021	BUY	$105.21 - $117.21 $23,461 - $26,137	223 Added 6.42%	3,695 $432,000
Q1 2021 May 07, 2021	SELL	$102.3 - $112.62 $9,923 - $10,924	-97 Reduced 2.72%	3,472 $373,000
Q4 2020 Feb 12, 2021	BUY	$80.49 - $108.67 $2,173 - $2,934	27 Added 0.76%	3,569 $382,000
Q3 2020 Nov 10, 2020	BUY	$85.91 - $100.83 $257 - $302	3 Added 0.08%	3,542 $310,000
Q2 2020 Jul 27, 2020	SELL	$73.37 - $98.18 $25,386 - $33,970	-346 Reduced 8.91%	3,539 $347,000
Q1 2020 Apr 30, 2020	SELL	$64.5 - $97.79 $83,656 - $126,833	-1,297 Reduced 25.03%	3,885 $296,000
Q4 2019 Feb 07, 2020	BUY	$72.13 - $90.25 $373,777 - $467,675	5,182 New	5,182 $458,000

3,693

1.27B

13M

9.79M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $341B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Capital Square, LLC, based on Form 13F filings with the SEC.

Stay updated on Capital Square, LLC with notifications on news.